{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:11:37Z","timestamp":1790655097494,"version":"4.1.0"},"reference-count":44,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T00:00:00Z","timestamp":1734825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Indiana University","award":["4583229"],"award-info":[{"award-number":["4583229"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Hypertension remains a global health challenge due to its high prevalence and association with premature morbidity and mortality. Aldosterone, a mineralocorticoid hormone, and its receptor, the mineralocorticoid receptor (MR), are highly implicated in hypertension pathogenesis. Aldosterone synthase is the sole enzyme responsible for producing aldosterone in humans. We established transgenic mice carrying the human aldosterone synthase gene (cyp11B2) and showed dramatically increased levels of aldosterone in female hemizygotes. High-salt diets persistently increased blood pressure in these mice, and salt-induced hypertension was significantly ameliorated by reducing aldosterone levels via an aldosterone synthase inhibitor or blocking MR via an MR inhibitor. Since both hypertension and hyperaldosteronism specifically induce chronic kidney disease, in this model, we demonstrated that chronic high-salt diets induced hypertension in this mouse line and resulted in kidney inflammation and injury. Both the aldosterone synthase inhibitor and the MR antagonist markedly blocked high-salt-diet-mediated kidney injury. Thus, this transgenic mouse line can be used to study the pathogenic mechanisms underlying aldosterone and its receptor and to screen therapeutic compounds for aldosterone-mediated hypertension and related complications, such as kidney disease, in humans.<\/jats:p>","DOI":"10.3390\/biology13121084","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T02:39:56Z","timestamp":1734921596000},"page":"1084","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Effects of Aldosterone on Hypertension-Associated Kidney Injury in a Tg-hAS Mouse Model"],"prefix":"10.3390","volume":"13","author":[{"given":"Huiying","family":"Gu","sequence":"first","affiliation":[{"name":"Department of Neurology, Indiana University School of Medicine, Indianapolis, IN 46202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Indiana University School of Medicine, Indianapolis, IN 46202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Du","sequence":"additional","affiliation":[{"name":"Boston Children\u2019s Hospital, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Indiana University School of Medicine, Indianapolis, IN 46202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqi","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Indiana University School of Medicine, Indianapolis, IN 46202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansheng","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Neurology, Indiana University School of Medicine, Indianapolis, IN 46202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,22]]},"reference":[{"key":"ref_1","first-page":"e40725","article-title":"Renin-Angiotensin System: Updated Understanding and Role in Physiological and Pathophysiological States","volume":"15","author":"Kanugula","year":"2023","journal-title":"Cureus"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrneph.2013.110","article-title":"Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis","volume":"9","author":"Brown","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/MNH.0b013e32834fb25b","article-title":"Extrarenal effects of aldosterone","volume":"21","author":"Jaisser","year":"2012","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_4","first-page":"661","article-title":"Primary aldosteronism","volume":"45","author":"Conn","year":"1955","journal-title":"J. Lab. Clin. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1126\/science.123.3195.503","article-title":"Human arterial hypertension: A state of mild chronic hyperaldosteronism?","volume":"123","author":"Genest","year":"1956","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lin, X., Ullah, M.H.E., Wu, X., Xu, F., Shan, S.-K., Lei, L.-M., Yuan, L.-Q., and Liu, J. (2021). Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.798364"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3317\/jraas.2005.006","article-title":"Angiotensin II receptor blockade and ventricular remodelling","volume":"6","author":"Anavekar","year":"2005","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/01.HYP.0000078357.92682.EC","article-title":"Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling","volume":"42","author":"Pu","year":"2003","journal-title":"Hypertension"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"i62","DOI":"10.1093\/ndt\/gft402","article-title":"Aldosterone synthase inhibitors in cardiovascular and renal diseases","volume":"29","author":"Namsolleck","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.107.095489","article-title":"Aldosterone and vascular inflammation","volume":"51","author":"Brown","year":"2008","journal-title":"Hypertension"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1182\/blood-2005-04-1723","article-title":"Ligand-specific glucocorticoid receptor activation in human platelets","volume":"106","author":"Moraes","year":"2005","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Martin-Fernandez, B., Rubio-Navarro, A., Cortegano, I., Ballesteros, S., Al\u00eda, M., Cannata-Ortiz, P., Olivares-\u00c1lvaro, E., Egido, J., de Andr\u00e9s, B., and Gaspar, M.L. (2016). Aldosterone Induces Renal Fibrosis and Inflammatory M1-Macrophage Subtype via Mineralocorticoid Receptor in Rats. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0145946"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MED.0b013e3283391989","article-title":"Aldosterone and inflammation","volume":"17","author":"Gilbert","year":"2010","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1517\/13543784.2015.1059819","article-title":"Finerenone : Third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease","volume":"24","author":"Liu","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1011119003788","article-title":"The EPHESUS trial: Eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study","volume":"15","author":"Pitt","year":"2001","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrneph.2012.217","article-title":"Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy","volume":"8","author":"Roscioni","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ki.2011.505","article-title":"Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: Current concepts and emerging treatment paradigms","volume":"81","author":"Shavit","year":"2012","journal-title":"Kidney Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mce.2009.02.005","article-title":"New aspects of rapid aldosterone signaling","volume":"308","author":"Grossmann","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/01.HYP.0000259797.48382.b2","article-title":"Nongenomic actions of aldosterone on the renal tubule","volume":"49","author":"Good","year":"2007","journal-title":"Hypertension"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.steroids.2005.02.004","article-title":"Nongenomic effects of mineralocorticoid receptor activation in the cardiovascular system","volume":"70","author":"Mihailidou","year":"2005","journal-title":"Steroids"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/hrt.82.1.57","article-title":"How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?","volume":"82","author":"MacFadyen","year":"1999","journal-title":"Heart"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.CIR.100.10.1056","article-title":"Comparison of candesartan, enalapril, and their combination in congestive heart failure: Randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators","volume":"100","author":"McKelvie","year":"1999","journal-title":"Circulation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ncpneph0575","article-title":"The incidence and implications of aldosterone breakthrough","volume":"3","author":"Bomback","year":"2007","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/01.HYP.0000201443.63240.a7","article-title":"Effects of aldosterone on the vasculature","volume":"47","author":"Schiffrin","year":"2006","journal-title":"Hypertension"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1210\/en.2016-1358","article-title":"Aldosterone Synthase Inhibition Improves Glucose Tolerance in Zucker Diabetic Fatty (ZDF) Rats","volume":"157","author":"Hofmann","year":"2016","journal-title":"Endocrinology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: A retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"11068","DOI":"10.1074\/jbc.RA120.013047","article-title":"Effects of intron conversion in the human CYP11B2 gene on its transcription and blood pressure regulation in transgenic mice","volume":"295","author":"Mopidevi","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1038\/s41467-022-29242-3","article-title":"Author Correction: Elevated aldosterone and blood pressure in a mouse model of familial hyperaldosteronism with ClC-2 mutation","volume":"13","author":"Schewe","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Gu, H., Ma, Z., Wang, J., Zhu, T., Du, N., Shatara, A., Yi, X., Kowala, M.C., and Du, Y. (2017). Salt-dependent Blood Pressure in Human Aldosterone Synthase-Transgenic Mice. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-00461-9"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1146\/annurev-physiol-022516-034219","article-title":"Macrophages in Renal Injury and Repair","volume":"79","author":"Huen","year":"2017","journal-title":"Annu. Rev. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1007\/s12035-018-1228-0","article-title":"IVIG Delays Onset in a Mouse Model of Gerstmann-Straussler-Scheinker Disease","volume":"56","author":"Gu","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Zhang, A., Li, M., Qiu, J., Sun, J., Su, Y., Cai, S., Bao, Q., Cheng, B., Ma, S., and Zhang, Y. (2022). The relationship between urinary albumin to creatinine ratio and all-cause mortality in the elderly population in the Chinese community: A 10-year follow-up study. BMC Nephrol., 23.","DOI":"10.1186\/s12882-021-02644-z"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/MNH.0000000000000595","article-title":"The varying roles of macrophages in kidney injury and repair","volume":"29","author":"Wen","year":"2020","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/ndt\/gfl691","article-title":"PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis","volume":"22","author":"Boor","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.metabol.2009.05.025","article-title":"Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats","volume":"58","author":"Boor","year":"2009","journal-title":"Metabolism"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","article-title":"Renal damage in primary aldosteronism: A systematic review and meta-analysis","volume":"38","author":"Monticone","year":"2020","journal-title":"J. Hypertens."},{"key":"ref_40","first-page":"97","article-title":"Aldosterone: Refreshing a slow hormone by swift action","volume":"19","author":"Boldyreff","year":"2004","journal-title":"News Physiol. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1097\/HJH.0b013e328330a963","article-title":"Aldosterone induces arterial stiffness in absence of oxidative stress and endothelial dysfunction","volume":"27","author":"Leibovitz","year":"2009","journal-title":"J. Hypertens."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.109.131110","article-title":"Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone\/salt-induced cardiac fibrosis and increased blood pressure","volume":"54","author":"Rickard","year":"2009","journal-title":"Hypertension"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa003417","article-title":"Impact of high-normal blood pressure on the risk of cardiovascular disease","volume":"345","author":"Vasan","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_44","first-page":"110","article-title":"The Role of Aldosterone in Hypertension and Related Morbidities","volume":"1","author":"Stevens","year":"2018","journal-title":"Ann. Hypertens."}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/13\/12\/1084\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:57:52Z","timestamp":1760115472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/13\/12\/1084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,22]]},"references-count":44,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["biology13121084"],"URL":"https:\/\/doi.org\/10.3390\/biology13121084","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,22]]}}}